Angioinvasive lymphomatoid papulosis: A new variant simulating aggressive lymphomas

American Journal of Surgical Pathology

Volumn 37, Issue 1, 2013, Pages 1-13

  Kempf, Werner ^a,b   Kazakov, Dmitry V ^c   Schärer, Leo ^d   Rütten, Arno ^d   Mentzel, Thomas ^d   Paredes, Bruno E ^d   Palmedo, Gabriele ^d   Panizzon, Renato G ^e   Kutzner, Heinz ^d  

^a Kempf und Pfaltz Histologische Diagnostik   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Dermatopathologie Friedrichshafen ^*  (Germany)

^e Centre Hospitalier Universitaire Vaud   (Switzerland)

Author keywords

angiotropic; CD30; CD8; cytotoxic lymphoma; lymphoma; lymphomatoid papulosis; skin

Indexed keywords

CD30 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CD8+ T LYMPHOCYTE; CHILD; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GENETICS; HUMAN; LYMPHOMATOID PAPULOSIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REMISSION; RETROSPECTIVE STUDY; SKIN TUMOR; TUMOR REGRESSION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD30; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM REGRESSION, SPONTANEOUS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84871618825     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182648596     Document Type: Article

References (70)

1. Duvic M. CD30+ neoplasms of the skin. Curr Hematol Malignancy Reports. 2011;6:245-250.
2. Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lympho-matoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011;118:4024-4035.
3. Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32:647-674.
4. Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006;33(suppl 1):58-70.
5. LeBoit PE. Lymphomatoid papulosis and cutaneous CD30+ lymphoma. Am J Dermatopathol. 1996;18:221-235.
6. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 1993;28:973-980.
7. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
8. Saggini A, Gulia A, Argenyi Z, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases. Am J Surg Pathol. 2010;34:1168-1175.
9. El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol. 2004;140:441-447.
10. Boulland ML, Wechsler J, Bagot M, et al. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology. 2000;36:136-144.
11. Kummer JA, Vermeer MH, Dukers D, et al. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol. 1997;109:636-640.
12. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653-3661.
13. Kadin M, Nasu K, Sako D, et al. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol. 1985;119:315-325.
14. Kneba M, Bolz I, Linke B, et al. Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing. Blood. 1994;84:574-581.
15. Ponte P, Serrao V, Viana I, et al. Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin. J Cutan Pathol. 2012;38:301-305.
16. Belousova IE, Nemcova J, Kacerovska D, et al. Atypical histopathological features in cutaneous lymphoid hyperplasia of the scrotum. Am J Dermatopathol. 2008;30:407-408.
17. Boudova L, Kazakov DV, Sima R, et al. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol. 2005;27:375-386.
18. Kazakov DV, Belousova IE, Kacerovska D, et al. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphopro-liferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas. Am J Surg Pathol. 2008;32:1468-1478.
19. Greisser J, Palmedo G, Sander C, et al. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol. 2006;33:711-715.
20. Aoki E, Aoki M, Kono M, et al. Two cases of lymphomatoid papulosis in children. Ped Dermatol. 2003;20:146-149.
21. Berti E, Tomasini D, Vermeer MH, et al. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483-492.
22. Hellman J, Phelps RG, Baral J, et al. Lymphomatoid papulosis with antigen deletion and clonal rearrangement in a 4-year-old boy. Ped Dermatol. 1990;7:42-47.
23. Kadin ME. Characteristic immunologic profile of large atypical cells in lymphomatoid papulosis. Possible implications for histogenesis and relationship to other diseases. Arch Dermatol. 1986;122:1388-1390.
24. Magro CM, Crowson AN, Morrison C, et al. CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol. 2006;125:490-501.
25. Wu WM, Tsai HJ. Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma: a case report. Am J Dermatopathol. 2004;26:133-135.
26. Bekkenk MW, Kluin PM, Jansen PM, et al. Lymphomatoid papulosis with a natural killer-cell phenotype. Brit J Dermatol. 2001;145:318-322.
27. Kim DS, Choi YJ, Oh SH, et al. A case of indolent CD56-positive lymphomatoid papulosis. J Am Acad Dermatol. 2010;63:e114-e116.
28. de Souza A, Camilleri MJ, Wada DA, et al. Clinical, histopatho-logic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients. J Am Acad Dermatol. 2009;61:993-1000.
29. Ferenczi K, Summers P, Aubert P, et al. A case of CD30+ nasal natural killer/T-cell lymphoma. Am J Dermatopathol. 2008;30:567-571.
30. Laetsch B, Hofbauer G, Kempf W, et al. Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis. Dermatology. 2005;210:341-345.
31. Magana M, Sangueza P, Gil-Beristain J, et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol. 1998;38:574-579.
32. Magro CM, Dyrsen M. Angiocentric lesions of the head and neck. Head Neck Pathol. 2008;2:116-130.
33. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28:719-735.
34. Natkunam Y, Warnke RA, Haghighi B, et al. Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases. J Cutan Pathol. 2000;27:392-399.
35. Pan ST, Chang WS, Murphy M, et al. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma. Am JDermatopathol. 2011;33:e17-e20.
36. Tao J, Shelat SG, Jaffe ES, et al. Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3-, natural killer (NK)-like cytotoxic T-cell lymphoma. Am J Surg Pathol. 2002; 26:111-118.
37. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627.
38. Urrutia S, Piris MA, Orradre JL, et al. Cytotoxic/suppressor (CD8+, CD4\) cutaneous T-cell lymphoma with aggressive course. Am J Dermatopathol. 1990;12:603-606.
39. Agnarsson BA, Vonderheid EC, Kadin ME. CD8+ cutaneous T-cell lymphoma. Am J Dermatopathol. 1991;13:628-629.
40. Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990;22:569-577.
41. Garcia-Herrera A, Song JY, Chuang SS, et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol. 2011;35:1214-1225.
42. Kinney MC, Jones D. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types. Am J Clin Pathol. 2007;127:670-686.
43. Kluin PM, Feller A, Gaulard P, et al. Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology. 2001;38:250-270.
44. Rodriguez-Pinilla SM, Barrionuevo C, Garcia J, et al. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults. Am J Surg Pathol. 2010;34:1773-1782.
45. Rodriguez J, Romaguera JE, Manning J, et al. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma. 2000;39:139-144.
46. Assaf C, Gellrich S, Whittaker S, et al. CD56-positive haemato-logical neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol. 2007;60:981-989.
47. Berti E, Cerri A, Cavicchini S, et al. Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid retic-ulosis. J Invest Dermatol. 1991;96:718-723.
48. Kadin ME. Cutaneous gamma delta T-cell lymphomas-how and why should they be recognized? Arch Dermatol. 2000;136:1052-1054.
49. Ghobrial IM, Weenig RH, Pittlekow MR, et al. Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma. 2005;46:703-708.
50. Kong YY, Dai B, Kong JC, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32:1495-1502.
51. Kumar S, Krenacs L, Medeiros J, et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol. 1998;29:397-403.
52. Lozzi GP, Massone C, Citarella L, et al. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol. 2006;28: 9-12.
53. Magro CM, Crowson AN, Byrd JC, et al. Atypical lymphocytic lobular panniculitis. J Cutan Pathol. 2004;31:300-306.
54. Marzano AV, Berti E, Paulli M, et al. Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases. Arch Dermatol. 2000;136:889-896.
55. Massone C, Lozzi GP, Egberts F, et al. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat. J Cutan Pathol. 2006;33:418-425.
56. Pincus LB, LeBoit PE, McCalmont TH, et al. Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopatho-logic features of lupus erythematosus: coexistence of 2 entities? Am J Dermatopathol. 2009;31:520-526.
57. Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22:881-893.
58. Sawada Y, Hino R, Hama K, et al. Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lympho-ma. Blood. 2011;117:3961-3967.
59. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma: an elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature. Am J Dermatopathol. 2001;23:206-215.
60. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous pannicu-litis-like T-cell lymphoma: definition, classification and prognostic factors. An EORTC Cutaneous Lymphoma Group study of 83 cases. Blood. 2008;111:838-845.
61. Sciallis AP, Law ME. Inwards DJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinic-opathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol. 2012;25: 983-992.
62. de Souza A, Gibson LE, Wada DA, et al. Resolution of CD8+ lymphomatoid papulosis after surgical excision of the type AB-thymoma. Am J Dermatopathol. 2009;31:475-479.
63. Massone C, El-Shabrawi-Caelen L, Kerl H, et al. The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants. J Cutan Pathol. 2008;35:46-53.
64. Xu H, Qian J, Wei J, et al. CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques. Eur J Dermatol. 2011;21:609-610.
65. Kadin ME. Pathobiology of CD30+ cutaneous T-cell lymphomas. J Cutan Pathol. 2006;33(suppl 1):10-17.
66. Kadin ME, Levi E, Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand. Ann N Y Acad Sci. 2001;941:59-68.
67. el-Azhary RA, Gibson LE, Kurtin PJ, et al. Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies. J Am Acad Dermatol. 1994;30:210-218.
68. Nijsten T, Curiel-Lewandrowski C, Kadin ME. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. Arch Dermatol. 2004;140:306-312.
69. Van Neer FJ, Toonstra J, Van Voorst Vader PC, et al. Lymphomatoid papulosis in children: a study of 10 children registered by the Dutch Cutaneous Lymphoma Working Group. Br J Dermatol. 2001;144:351-354.
70. de Souza A, El-Azhary RA, Camilleri MJ, et al. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol. 2012;66:928-937.